Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036388/0/en/Cybrexa-Therapeutics-Announces-New-Preclinical-Data-on-Tumor-Selective-Peptide-Drug-Conjugates-at-ESMO-Targeted-Anticancer-Therapies-Congress-2025.html
07 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/07/2958808/0/en/Cybrexa-Therapeutics-Announces-First-Patient-Dosed-with-First-in-Class-Peptide-Drug-Conjugate-CBX-12-in-Phase-2-Trial-in-Ovarian-Cancer.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946456/0/en/Cybrexa-Therapeutics-Announces-Positive-Final-Data-at-ESMO-2024-from-Phase-1-Study-of-Peptide-Drug-Conjugate-CBX-12-in-Advanced-Solid-Tumors.html
25 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/25/2903762/0/en/Industry-Leader-John-Maraganore-Ph-D-Joins-Cybrexa-Therapeutics-as-Strategic-Advisor.html
06 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/06/2824260/0/en/Cybrexa-Regains-Rights-to-CBX-12.html
10 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/10/2757453/0/en/Cybrexa-Therapeutics-to-Debut-Preclinical-Data-Demonstrating-CBX-15-is-Safe-and-Highly-Efficacious-in-13762-Triple-Negative-Breast-Cancer-Model-at-35th-AACR-NCI-EORTC-Symposium.html
ABOUT THIS PAGE